252 related articles for article (PubMed ID: 3759127)
21. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
Balkarowa-Ständer J; Rother U; Rauterberg EW
J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
[TBL] [Abstract][Full Text] [Related]
22. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
Nemerow GR; Yamamoto KI; Lint TF
J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
[No Abstract] [Full Text] [Related]
23. The structural events associated with the attachment of complement components to cell membranes in reactive lysis.
Dourmashkin RR
Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370
[TBL] [Abstract][Full Text] [Related]
24. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Wiedmer T; Sims PJ; Rosse WF
J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
[TBL] [Abstract][Full Text] [Related]
26. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
Brade V; Beuscher HU
Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
[TBL] [Abstract][Full Text] [Related]
27. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
Nemerow GR; Gewurz H; Osofsky SG; Lint TF
J Clin Invest; 1978 Jun; 61(6):1602-10. PubMed ID: 350902
[TBL] [Abstract][Full Text] [Related]
28. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.
Baker PJ; Osofsky SG
Clin Exp Immunol; 1981 Mar; 43(3):549-56. PubMed ID: 6912799
[TBL] [Abstract][Full Text] [Related]
30. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
Zimmerman TS; Kolb WP
J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
[TBL] [Abstract][Full Text] [Related]
31. Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria.
Rother U; Hänsch G; Menzel J; Rother K
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):172-86. PubMed ID: 4283273
[No Abstract] [Full Text] [Related]
32. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
Hammer CH; Nicholson A; Mayer MM
Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
[TBL] [Abstract][Full Text] [Related]
33. The modifications of the final stages of the complement reaction by alkali metal cations.
Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
[TBL] [Abstract][Full Text] [Related]
34. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
Packman CH; Rosenfeld SI; Weed RI; Leddy JP
J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
[TBL] [Abstract][Full Text] [Related]
35. [Complement system].
Korol' SA
Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
[No Abstract] [Full Text] [Related]
36. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
37. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
Mak LW
Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
[TBL] [Abstract][Full Text] [Related]
38. Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.
Rother U; Hänsch G; Rother K
Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):442-54. PubMed ID: 785847
[TBL] [Abstract][Full Text] [Related]
39. Terminal complement components play a role in the expression of C5a.
Gresham HD; Renfer L; Hammer CH; Frank MM
J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
[TBL] [Abstract][Full Text] [Related]
40. Reaction of partial identity between the C56-9 complex derived from target membranes and from inulin-activated serum.
Bhakdi S; Bhakdi-Lehnen B; Ey P; Bjerrum OJ
Monogr Allergy; 1977; 12():56-61. PubMed ID: 411027
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
